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Activation of Phosphoinositide
3-Kinase  by Ras
the inositol ring to produce phosphatidylinositol (3,4,5)-
trisphosphate [PtdIns(3,4,5)P3]. This latter accumulates
in the inner leaflet of the plasma membrane and initiates
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Babraham a cascade of downstream signals by causing membrane
recruitment of proteins that bind specifically the distinc-CB2 4AT Cambridge
United Kingdom tive head group of this phosphoinositide [3].
There are two types of class I PI3Ks, both of which are
heterodimeric molecules composed of a p110 catalytic
subunit and a regulatory subunit. The class IA enzymesSummary
contain a p110 , , or  catalytic subunit and an SH2
domain-containing adaptor subunit, p85, p85, or p55,Background: Type I phosphoinositide 3-kinases are re-
derived from three possible genes (or their splice vari-sponsible for the hormone-sensitive synthesis of the
ants). Class IA can be activated directly by the associa-lipid messenger phosphatidylinositol(3,4,5)-trisphos-
tion of the SH2 domains of their regulatory subunitsphate. Type IA and IB subfamily members contain a Ras
with appropriate phosphotyrosines, often located in thebinding domain and are stimulated by activated Ras
cytoplasmic tail of receptor tyrosine kinases [4]. Class IBproteins both in vivo and in vitro. The mechanism of
contains only one member, PI3K, that is composed of aRas activation of type I PI3Ks is unknown, in part be-
p101 regulatory subunit and a p110 catalytic subunit.cause no robust in vitro assay of this event has been
This enzyme is regulated by G subunits liberated uponestablished and characterized. Other Ras effectors,
activation of heterotrimeric G proteins. The p101 regula-such as Raf and phosphoinositide-phospholipase C,
tory subunit is critical for G-activated PtdIns(3,4,5)P3have been shown to be translocated into the plasma
production [5, 6]. All class I PI3Ks have a region thatmembrane, leading to their activation.
is similar to the Ras binding domain (RBD) present inResults: We show that posttranslationally lipid-modi-
proteins that are regulated by the monomeric GTPasefied, activated N-, H-, K-, and R-Ras proteins can po-
Ras. Furthermore, all class I PI3Ks bind Ras in a GTP-tently and substantially activate PI3K when using a
dependent manner [7–9].stripped neutrophil membrane fraction as a source of
The Ras family operates in diverse signaling pathwaysphospholipid substrate. We have found GTPS-loaded
that regulate cell growth, differentiation, and survival.Ras can significantly (6- to 8-fold) activate PI3K when
They function as molecular switches by cycling betweenusing artificial phospholipid vesicles containing their
the inactive GDP-bound state and the active GTP-boundsubstrate, and this effect is a result of both a decrease
state. The exchange of GDP to GTP causes two regions,in apparent Km for phosphatidylinositol(4,5)-bisphos-
switch I and switch II, to change conformation, allowingphate and an increase in the apparent Vmax. However,
Ras to bind and activate multiple downstream effectors.neither in vivo nor in the two in vitro assays of Ras
Most Ras-dependent signaling is mediated by threeactivation of PI3K could we detect any evidence of a
downstream effectors: the protein kinase Raf, the ex-Ras-dependent translocation of PI3K to its source of
change factor RalGDS, and PI3Ks [10].phospholipid substrate.
Within the class I PI3Ks, the activation of PI3K byConclusions: Our data suggest that Ras activate PI3K
Ras has been the most studied [11, 7, 8]. In vitro, Rasat the level of the membrane, by allosteric modulation
activation of type IA PI3K is synergistic with the stimula-and/or reorientation of the PI3K, implying that Ras can
tion by tyrosine-phosphorylated peptide. In PC12 cells,activate PI3Kwithout its membrane translocation. This
the action of NGF and EGF on PtdIns(3,4,5)P3 productionview is supported by structural work that has suggested
is reduced by a dominant-negative Ras mutant [7]. Di-binding of Ras to PI3K results in a change in the struc-
rect interaction of Ras with PI3K stimulated actin re-ture of the catalytic pocket.
arrangement and inhibited programmed cell death upon
detachment from the extracellular matrix [12]. Other
Introduction consequences of Ras activation of PI3Ks include cell
transformation [13], T cell adhesion and migration [14],
Phosphatidylinositol 3-kinase (PI3K) activity plays a cen- and blocking of apoptosis induced by c-Myc [15] or by
tral role in cell signaling and can lead to cell prolifera- NGF deprivation [16].
tion, survival, motility, exocytosis, and cytoskeletal re- We have previously reported the strong and direct
arrangements as well as specialized cell responses, activation of PI3K by H-Ras in vitro and in vivo. Indeed,
such as superoxide production and cardiac myocyte crystal structures revealed a direct interaction of Ras
growth [1–2]. Mammalian PI3Ks are divided into three with the COOH-terminal part of the catalytic domain of
classes based on their structure and substrate specific- p110 and a difference in the conformation of the cata-
ity. Upon activation by cell surface receptors, class I lytic domain between p110 and Ras:p110 [17]. How-
PI3Ks phosphorylate preferentially phosphatidylinositol ever, the exact mechanism involved in the activation of
(4,5)-bisphosphate [PtdIns(4,5)P2] on the D3 position of PI3K by Ras has not yet been elucidated.
Here, we describe the characterization of two distinct
in vitro assays of Ras-dependent activation of PI3K1Correspondence: len.stephens@bbsrc.ac.uk
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Figure 1. Activation of PI3K by Ras In Vitro
Activation of PI3K by posttranslationally
modified H-Ras, N-Ras, K-Ras, and R-Ras,
using pig neutrophils membranes as a sub-
strate. The final concentration of the Ras (cor-
rected for the proportion that inserted into the
membranes and could bind GTP) and PI3K
were 15 and 30 nM, respectively. They were
incubated with [32P]-ATP and a neutrophil
membrane fraction for 3 min. The assays
were stopped and [32P]-labeled phosphoino-
sitides were extracted, deacylated, sepa-
rated by HPLC, and quantified by scintillation
counting. The data for [32P]-PtdIns(3)P
[PI(3)P], [32P]-PtdIns(3,4)P2 [PI(3,4)P2], and
[32P]-PtdIns(3,4,5)P3 [PI(3,4,5)P3] are shown.
The data shown are from a representative
experiment (of two to three experiments) and
were normalized via the [32P]-PtdIns(4)P pro-
duced during the assay.
that we use, in parallel with experiments utilizing intact PtdIns(3,4)P2 and PtdIns3P accumulation; these data
closely paralleled results with PtdIns(3,4,5)P3.cells, to address the mechanism by which Ras proteins
activate PI3K.
PI3K Activation Dependent on Ras
Lipid ModificationResults
All of the above work used Sf9-derived Ras proteins
purified via a Triton X114 extraction procedure (thatAll GTP-Ras Isoforms Activate PI3K
does not recover Ras proteins without lipid modifica-To determine the activation of PI3K by the different
tions). These lipid-modified Ras proteins all insertedRas isoforms (H-, N-, K-) and their close relative R-Ras,
substantially into the membranes used in our in vitrowe investigated the effect of full-length lipid-modified
assays (20%–40%, depending on the Ras isoforms, seeGDP or GTPS-loaded Ras on PI3K activity in vitro. The
Figure 6 and below). To see whether membrane localiza-assays used a plasma membrane-enriched membrane
tion of Ras was required to enable activation of PI3K,fraction from neutrophils as a source of lipid substrates.
we tested the ability of bacterially produced, nonmodi-Our results showed that all GTPS-loaded Ras isoforms
fied H-Ras to activate PI3K on neutrophil membranesactivated PI3K (Figure 1). With approximately 15 nM
in a assay of the above format (Figure 3). UnmodifiedRas proteins (corrected for both GTPS binding and the
GTPS-Hras was able to bind p110 (data not shown,proportion of the Ras proteins inserted into the neutro-
see [17]) and significantly activated PI3K, but in termsphils membranes in the assays), a 30-fold increase of
of fold above GDP-loaded control, the effect was re-PI3K activity was observed with R-Ras and K-Ras,
duced by more than 10-fold, and similarly, the absolutewhereas, in the presence of H-Ras and N-Ras, a 10-fold
levels of activity were also substantially reduced com-increase was measured. These activations were strictly
pared to Sf9-derived H-Ras.GTPS dependent; no stimulation was found with the
relevant GDP-loaded Ras proteins.
Ras Activation of PI3K in Stripped
Neutrophil MembranesR-Ras and K-Ras Are More Potent Activators
To investigate whether the action of Ras on PI3K activ-than H-Ras and N-Ras
ity in the neutrophil membranes was mediated by anTo investigate the differences among the Ras isoforms’
additional protein, we stripped the membranes ofabilities to activate PI3K, a large range of Ras concen-
weakly and strongly associated proteins by washingtrations from 0.5 nM to 250 nM was tested (Figure 2).
them with urea (2.5 M) or high (1 M NaCl) or low (2.5Again, these data were corrected for both the GTPS
mM HEPES) salt buffers and then assayed PI3K activa-binding and the extent of membrane insertion shown by
tion in the presence of H-Ras, using the protocol de-each Ras protein. At Ras concentrations below 10 nM,
scribed before. None of the membrane treatments re-the production of PtdIns(3,4,5)P3 stimulated by R-Ras
duced the fold activation of PI3K activity by H-Rasand K-Ras was ten times higher than that with H- and
(Figure 4).N-Ras, demonstrating that at lower concentrations
R-Ras and K-Ras are more potent activators of PI3K
than H-Ras and N-Ras. Ras-Dependent Activation of PI3K on Mixed
Phospholipid LiposomesWith H-Ras and N-Ras, we were limited by the final
percent cholate we could accommodate in the assays We prepared liposomes containing phosphatidylserine,
phosphatidylcholine, phosphatidylethanolamine, sphin-and the relatively low concentration of the H- and N-Ras
stocks to a maximum final concentration of 100 nM and gomyelin, and cholesterol, in proportions similar to
those thought to be present in the inner leaflet of the50 nM, respectively.
In all of the above experiments, we also quantified plasma membrane, with various concentrations of phos-
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Figure 2. K-Ras and R-Ras Are More Potent
Activators of PI3K than H-Ras and N-Ras In
Vitro
Activation of PI3K by posttranslationally
modified H-Ras, N-Ras, K-Ras, and R-Ras, us-
ing pig neutrophils membranes as a substrate.
A large range of Ras concentrations (corrected
as in Figure 1) was used in the presence of
30 nM PI3K. Samples were processed and
quantified as described in Figure 1.
phatidylinositol(4,5)-bisphosphate [PtdIns(4,5)P2, 1 M Ras; this proportion did not change when it was coex-
pressed with H-RasG12V, a constitutive-active mutant,to 100 M] (Figure 5). As expected, PI3K phosphory-
lated the PtdIns(4,5)P2 in these liposomes. Ras proteins and H-RasN17S, a dominant-inhibitory mutant. We have
published the results of precisely parallel experimentsefficiently inserted into these liposomes (see below). In
the presence of 50M PtdIns(4,5)P2 (apparently saturat- in which we measured the levels of PtdIns(3,4,5)P3 and
PtdIns(3,4)P2, that showed under these conditions heter-ing for PI3K), GTPS-Rras but not GDP-Rras caused
a 2-fold increase in PI3K activity. This effect was sub- ologous H-RasG12V stimulated a 20- to 30-fold increase
in heterologous PI3K activity [17].stantially greater at lower PtdIns(4,5)P2 concentrations,
suggesting that the GTPS-Rras was acting to increase We then examined the distribution of PI3K between
centrifugation-generated pellets and supernatants in inthe apparent affinity of PI3K for PtdIns(4,5)P2.
vitro assays using neutrophil membrane fractions in
which we can measure substantial activation of PI3KRas Does Not Drive Membrane Translocation
of PI3K Either In Vivo or In Vitro by Ras proteins. We found 5%–8% of PI3Kwas associ-
ated with the neutrophil membranes in the absence ofTo examine whether the mechanism of Ras activation
of PI3K was dependent of PI3K translocation, we added Ras proteins. Although 20%–40% of the added,
Sf9-derived Ras proteins inserted into the membranes,coexpressed p101, p110, and different H-Ras alleles
in Cos-7 cells, and we determined their distribution in neither GDP- nor GTPS-loaded K-Ras (Figure 6B) or
H-Ras (data not shown) caused significant change inthe membrane and cytosolic fractions after serum star-
vation (Figure 6A). About 10% of PI3K was found in the amount of PI3K bound to the membranes.
We conducted similar experiments to assess the dis-the membrane fraction in the absence of heterologous
Figure 3. PI3K Activation Is Dependent on Lipid Modification of Ras
Activation of PI3K (30 nM final concentration) by posttranslationally modified H-Ras (left panel) (concentrations corrected as in Figure 1) and
unmodified H-Ras (right panel), using pig neutrophils membranes as a substrate. The assays were conducted, analyzed, and quantified as
described in Figure 1.
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Figure 4. Effects of Dissociating Proteins from the Substrate Membranes on the Ability of Ras to Activate PI3K
Activation of PI3K (30 nM final concentration) by posttranslationally modified H-Ras (15 nM final concentration, corrected as in Figure 1),
using treated pig neutrophil membranes as a substrate. The pig neutrophil membranes were pretreated with 2.5 M urea (2.5 M urea, 1 mM
KCl) or low salt (2.5 mM HEPES [pH 7.4], 0.1 mM EGTA, 0.5 mM DTT) or high salt (1 M NaCl) and then washed three times with the control
buffer (0.12 M NaCl, 1 mM EGTA, 20 mM HEPES [pH 7.4], 1 mM DTT). Assays were conducted and analyzed and quantified as described in
Figure 1 (except data were normalized to the average [32P]-PtdIns(4)P produced in membranes extracted by a particular procedure; see
Experimental Procedures).
Figure 5. Effect of Ras on PI3K Activity Us-
ing Mixed Phospholipid Vesicles as a Sub-
strate
Activation of PI3K (3 nM final concentration)
by posttranslationally modified Rras (20 nM
final concentration), using lipid vesicles as a
substrate. The final lipid concentrations in the
assay were 60 M phosphatidylserine, 125
M phosphatidylcholine, 125 M phosphati-
dylethanolamine, 20 M sphingomyelin, 125
M cholesterol, and phosphatidylinositol
(4,5)bisphosphate [PI(4,5)P2, 1M to 100M].
After 3 min incubation with [32P]-ATP, the
assays were stopped, and the total [32P] re-
covered in a lipid extract (above a no PI3K
control) was quantified by scintillation count-
ing. (A) Results are plotted as disintegration
per minute (dpm) of lipid product against the
concentration of PtdIns(4,5)P2 for PI3K with
or without GTPS or GDP-loaded R-Ras. The
data are means  ranges (n  2 to 5) from
five independent experiments. (B) The data in
(A), plotted as fold activation of PI3K activity
above control by GTPS-Rras against con-
centration of PtdIns(4,5)P2.
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Figure 6. Impact of Ras on the Distribution
of PI3K in Cos-7 Cells and Neutrophil Mem-
branes
(A) Cos-7 cells expressing the indicated pro-
teins were subjected to serum starvation for
18 hr and then lysed by sonication. Protein
concentrations in the lysates were deter-
mined, and equivalent amounts of proteins
were loaded on to a SDS-PAGE gel, trans-
ferred onto PDVF, and immunoblotted for
PI3K and Ras. The results are from a single
experiment (representative of two). The left
part of the figure represents the total fraction
(membrane and cytosol), and the right part
represents the content of the membrane
alone. About 2% of the total fraction and all
the membrane fraction were used.
(B) Neutrophil membranes were incubated
with GDP-Kras or GTPS-Kras for 15 min on
ice. After this time, PI3Kwas added, and the
mixture was incubated at 30	C. After 3 min,
the reactions were quenched and spun for 20
min at 13,000 
 g. Half of the supernatant
and the all pellet were loaded onto a SDS-
PAGE gel, transferred onto PDVF, and immu-
noblotted for PI3K and Ras. The results are
from a single experiment (representative of
two).
tribution of PI3K within assays containing synthetic, Ras isoforms, but its insertion mode within the plasma
membrane is still uncertain. However, previous resultsmixed, sucrose-loaded phospholipid vesicles (like those
studying the effects of G on PI3K activation [18]). have demonstrated that R-Ras can activate PI3K in
vivo [20].Neither GDP- nor GTPS-loaded Ras significantly in-
creased the amount of PI3K associated with the vesi- The hypervariable region (HVR) in Ras proteins, lo-
cated in the 25 C-terminal amino acids, is the only regioncles (data not shown).
where the highly homologous H-Ras, N-Ras, and K-Ras
substantially differ from each other and could henceDiscussion
explain the differential activation of PI3K. The HVR con-
tains two signal sequences that promote associationWe have shown previously that H-Ras can activate
PI3K directly both in vivo and in vitro [17]. Here, we with the plasma membrane by rendering them more
hydrophobic. The first signal is a CAAX box where eachhave demonstrated that N-Ras, H-Ras, K-Ras, and R-
Ras can stimulate the PI3Kactivity in vitro using neutro- of the Ras proteins becomes farnesylated, truncated,
and carboxymethylated. The second signal sequencephil membranes as a source of substrate. The ability
of this membrane fraction to support Ras-dependent consists of a polybasic stretch of six lysines in K-Ras
or a single or double palmitoylation in N-Ras or H-Ras,activation of PI3K was resistant to stringent protein-
stripping protocols, including washing with 2.5 M urea, respectively. Both signals are required to localize the
Ras isoforms to the plasma membrane [21]. We find thatsuggesting that nonintegral membrane proteins are not
essential. However, there are marked differences in the Ras requires posttranslational lipid modification to fully
activate p110, although they are not required foractivation of PI3K by the different Ras isoforms, such
that K-Ras and R-Ras are more potent activators of Ras:p110 binding [17]. This result confirms similar work
describing Ras-dependent activation of p110 in vitroPI3K than H-Ras and N-Ras. This was not a result of
a difference in the ability of the Ras proteins to insert [8]. The lipid modification of Ras proteins allows them
to insert into the neutrophil membranes or liposomesinto the membranes, as we corrected these data for the
amount of the Ras proteins that became membrane used in our assays. This insertion process effectively
substantially increases the local concentration of Rasassociated in these assays.
H-Ras, N-Ras, and K-Ras have a high degree of se- in the membrane phase where the PI3K is active. The
increased local concentrations of Ras in the membranequence homology ( 90%) and share exactly the same
effector binding domain as well as the specificity domain may be the sole reason for the difference between the
bacterial and Sf9-derived Ras proteins. However, it isthat surrounds it [19]. R-Ras forms a distinct branch of
the Ras subfamily and is 55% identical to H-Ras, N-Ras, additionally and/or alternatively possible that in the
membrane Ras makes an important and activating con-and K-Ras. Its minimal effector region is identical to the
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tribution to the orientation of PI3K at the interphase, changes (4- to 5-fold) in PI3K activity result directly from
SH2:phosphotyrosine docking [34, 35]. Moreover, sub-which is dependent on the Ras being lipid modified.
Contiguous, biological, phospholipid bilayer-based stantial evidence indicates that artificially targetting
both type IA and B PI3Ks to the plasma membrane leadsmembranes are now seen as complex structures that
can contain quite distinct domains of widely varying size to their constitutive activation (although these events
have not been demonstrated to be dependent purelyand with different lipid and protein compositions. Lipid
rafts and caveolae (characteristically containing the pro- on improved access to substrate lipids rather than im-
proved activation by proteins like Ras, it is very likelytein caveolin) are empirically defined microdomains of
the plasma membrane that appear to be rich in sphingo- to be the case). These observations show that PI3Ks
can be activated by translocation, but they do not meanlipids, glycosphingolipids, and cholesterol. It is clear that
a number of the key players in the signaling cassettes type I PI3Ks cannot be further activated once at the
level of the membrane [36]. We have also studied therelevant here are targeted in or out of these microdo-
mains. GDP-H-ras [22–25], receptor- (e.g., PDGF  re- mechanism by which Gs activate p110 and similarly
concluded that in in vitro assays, where we could detectceptor and EGF receptor) and Src-type tyrosine kinases
[26, 27], PtdIns(4,5)P2 (about 50% of the total [28]), and substantial G-elicited changes in PI3K activity, we
could find no evidence of translocation [18].G subunits [27, 29] are known to be concentrated,
whereas G subunits [29] and K-Ras [22, 23, 25] are Interestingly, structural studies have revealed
changes in the conformation of the catalytic site ofpreferentially scarce, in cholesterol-rich, detergent-
resistant microdomains. The factors which determine p110 are driven by binding of Ras. Although the RBD
of p110 is relatively distant from the catalytic domain,these distributions are not fully resolved, but in the case
of the Ras proteins, their covalent lipid modifications are particularly when viewed at the level of its primary struc-
ture, direct contacts between the switch II region of thevery important. These observations may explain several
features of our results and their relationship to other effector domain of Ras and the COOH-terminal part of
the catalytic domain have been observed and may un-published work. It has been reported, in apparent dis-
agreement with our work, that H-Ras was better than derlie the ability of Ras to allosterically activate PI3K.
Finally, we report that the activation of PI3K by RasK-Ras at activating type IA PI3Ks [30]. This may be a
result of the differential partitioning of type IA PI3Ks into which occurs at the level of the membrane is based on
two events. First, a decrease in the apparent Km ofmicrodomains enriched with receptor tyrosine kinases
which can activate them, where H-Ras but not K-Ras is PI3K for PtdIns(4,5)P2, and second, by a change in
Vmax and/or apparent Km for ATP. This is, to our knowl-also concentrated. In contrast, PI3K may differentially
partition into the bulk membrane, where Gs and K-Ras edge, the first report of a change in the apparent Km of
a PI3K for its phospholipid substrate in response to anare concentrated, hence explaining why K-Ras is a bet-
ter activator of PI3K than H-Ras. The polybasic region activator. This event may explain why other workers,
using saturating concentrations of phosphoinositidein K-Ras, in comparison to the palmitoyl moieties in
H-Ras and N-Ras, may be able to allow better associa- substrates, have failed to detect Ras-dependent activa-
tion of type I PI3Ks in vitro or have only detected cleartion with PtdIns(4,5)P2 in the bilayer, hence counter-
acting the fact that PtdIns(4,5)P2 is concentrated into effects in the context of other activators. Furthermore,
this may be at least part of the explanation for why wecholesterol-rich microdomains. Perhaps this ability of
the polybasic domain to improve the colocalization of can detect substantial effects of Ras on PI3K activity
in the context of neutrophil-derived membranes. ThereRas proteins with PtdIns(4,5)P2 and therefore for them
to act as better activators of PI3Ks explains the recent is good evidence that the levels of PtdIns(4,5)P2 in the
plasma membrane fall rapidly subsequent to cell disrup-report that switching the farnesyl group of H-Ras for
polybasic motif improved its ability to activate type IA tion and moreover that much of the PtdIns(4,5)P2 in cellu-
lar membranes is bound tightly to proteins, tending toPI3Ks [31].
We present data that show that in three very distinct lower its effective free concentration. However, there
is still a significant discrepancy between the scale ofcontexts both in vitro and in vivo, where we can demon-
strate clear GTP- or GTPS-Ras-dependent activation activation of PI3K by Ras in the context of liposomes
with low PtdIns(4,5)P2 (at best, 8- to 10-fold) comparedof PI3K, we can detect no Ras-driven redistribution of
PI3K. The implication of these results is that Ras activates to what we see in the context of stripped, neutrophil-
PI3K at the level of the membrane either via classical derived membrane fractions (up to 50-fold).
allosteric mechanism or by altering the orientation of
the PI3K within the surface of the membrane with re-
Experimental Proceduresspect to its phospholipids substrates. This contrasts
with works showing a translocation of PLC or Raf ki- Production of Recombinant Protein
nase into the plasma membrane caused by activation Posttranslationally modified H-Ras, N-Ras, K-Ras, and R-Ras were
[32, 33]. Some work suggests PI3Ks can be activated, obtained by infecting Sf9 cells with a baculovirus encoding the
relevant EE-tagged Ras and purified via Triton X114 phase partion-as a result of improved access to their substrate phos-
ing. They were then EE-directed immunoprecipitated as describedpholipids, by translocation to the plasma membrane.
[17] and stored at 80	C in a buffer containing 1% sodium cholate,This is presumed to apply in the case of type IA PI3Ks
10 M GDP, 1 mM DTT, 1 mM EGTA, 5 mM MgCl2, and elutingthat have been demonstrated to translocate to activated
peptide (150g/ml) at approximately 2–3 mg/ml. Nonmodified H-ras
receptor tyrosine kinases in the plasma membrane, be- was prepared as described [5]. PI3K was obtained by coinfecting
cause substantial increases in the PtdIns(3,4,5)P3 can Sf9 cells with baculovirus encoding His-tagged p110 and EE-
tagged p101 and purified via EE-tag [5].result, and yet in vitro studies suggest relatively small
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In Vitro Activity Measurements or irrelevant control DNA for a total of 30 g/transfection) in a final
volume of 0.5 ml as described previously [5]. After electroporation,All Ras isoforms were loaded with GTPS or GDP by incubation
with a 10-fold molar excess of the relevant nucleotide in 5 mM the cells were plated in 15 cm diameter dishes and incubated for
28 hr in complete growth medium (DMEM with 10% v/v FBS),EDTA/5 mM MgCl2. After 15 min at 20	C, MgCl2 was added to a final
concentration of 10 mM, and the proteins were frozen at 80	C washed, and then incubated in HEPES-buffered DMEM containing 1
mM NaHCO3 and 0.2% (w/v) fatty acid-free BSA (starvation medium).(care was taken to ensure these maneuvers did not significantly
change the pH of the solution). To assess the active concentration After 18 hr, the cells were washed with ice-cold PBS and collected
in lysis buffer (20 mM Tris [pH 8], 150 mM NaCl, 5 mM MgCl2, 10%of Ras, all Ras isoforms were diluted in 5 mM MgCl2, 1% cholate, 0.12
M NaCl, 40 mM HEPES, and 1 mM DTT. Then 2 l were incubated in glycerol, 1 mM EGTA, and protease inhibitors—see above) and lysed
by sonication. The lysates were separated into the membranes and5 l assay buffer (containing 0.12 M NaCl, 40 mM HEPES, 1% cho-
late, 2 mg/ml BSA, 1 mM EGTA, and 1 mM DTT) and 2.2 l of GTP the cytosolic fractions by ultracentrifugation at 100,000 
 g for 1
hr at 4	C. P110 and Ras were detected in the membrane andbuffer (containing 0.12 M NaCl, 40 mM HEPES, 5 mM EGTA with
cold and [35S]-GTPS at a final concentration of 10M). After incuba- cytosolic fractions by a rabbit polyclonal antibody (H-199, Santa
Cruz) and a mouse pan-Ras monoclonal antibody (Oncogene Re-tion at 20	C for 15 min, 5 ml of Stop buffer (containing 0.12 M NaCl,
40 mM HEPES, 0.12 M NaCl, and 1 mM DTT) was added. The mixture search Products), respectively.
was then applied onto a nitrocellulose filter (HA, 0.45 M) and
washed two times. The residual radioactivity on the filter was mea- Acknowledgments
sured by scintillation counting, and controls without Ras were used
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